LEY-22817-87368

3 vaccinations 8 coded responses 22 check-ins 8 free-text entries 3 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 481 / MI
Registered: 2020-12-18

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Registered in v-safe
2020-12-22
Dose 1 — Pfizer-BioNTech
2020-12-22
Survey response — day 0, dose 1
MedDRA: Immediate post-injection reaction, Paraesthesia — Feeling: Fair · Site: Pain · Fatigue or tiredness

Free text: Within 10 min of vaccine felt tingling in my fingers. Resolved after about an hour.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-29
Health check-in — day 7, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-03-23
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-06-22
Health check-in — 6 months, dose 1
Feeling: Good

Adult check-in
2021-11-03
Dose 3 — Pfizer-BioNTech
2021-11-05
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness

Adult check-in
2021-11-06
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Significant swelling of left axillary lympnode, extending into left breast area.

MedDRA releases: 2024-11 · check-in free text available
2021-11-06
Report sent to call center — days 1–6 daily, dose 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2021-11-07
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain

Free text: Swollen lymph nodes left axillary area

MedDRA releases: 2024-11 · check-in free text available
2021-11-08
Survey response — days 1–6 daily, dose 3
MedDRA: Dyspnoea, Lymphadenopathy — Feeling: Poor · Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Short of breath. Swollen lymph nodes left axillary.

MedDRA releases: 2024-11 · check-in free text available
2021-11-09
Survey response — days 1–6 daily, dose 3
MedDRA: Chest pain, Dyspnoea — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Shortness of breath, mild chest pain

MedDRA releases: 2024-11 · check-in free text available
2021-11-09
Report sent to call center — days 1–6 daily, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-10
Call 1 — Left Voicemail
2021-11-10
Call 1 — Left Voicemail
2021-11-12
Survey response — day 7, dose 3
MedDRA: Dyspnoea — Feeling: Fair · Fatigue or tiredness

Free text: Shortness of breath

MedDRA releases: 2024-11 · check-in free text available
2021-11-24
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-12-01
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-08
Survey response — day 35, dose 3
MedDRA: Oropharyngeal pain — Feeling: Good

Free text: Sore throat

MedDRA releases: 2024-11 · check-in free text available
2021-12-15
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-02-02
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-05-04
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-11-05
Survey response — 12 months, dose 3
MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: COVID + 8/12/22

MedDRA releases: 2024-11 · check-in free text available
2022-11-05
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
2022-11-07
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-11-07
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
2022-11-07
Call successful
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech	No
3	2021-11-03	Pfizer-BioNTech	No

Call center

3 call center cases

3 successful

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-22

Systemic reaction (other): Within 10 min of vaccine felt tingling in my fingers. Resolved after about an hour.

Release 10 — days 1–6 daily, dose 3

2021-11-06

Systemic reaction (other): Significant swelling of left axillary lympnode, extending into left breast area.

2021-11-07

Systemic reaction (other): Swollen lymph nodes left axillary area

2021-11-08

Systemic reaction (other): Short of breath. Swollen lymph nodes left axillary.

2021-11-09

Systemic reaction (other): Shortness of breath, mild chest pain

Release 10 — day 7, dose 3

2021-11-12

Systemic reaction (other): Shortness of breath

Release 10 — day 35, dose 3

2021-12-08

Symptoms: Sore throat

Release 12 — 12 months, dose 3

2022-11-05

Symptoms: COVID + 8/12/22

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SRO	Chest pain	·	·	✓
SRO	Dyspnoea	·	·	✓
SRO	Immediate post-injection reaction	✓	✓	✓
SRO	Lymphadenopathy	·	·	✓
SRO	Paraesthesia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release